Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Secukinumab”

197 trials

Showing 20 of 197 results

Testing effectiveness (Phase 2)Study completedNCT03131570
What this trial is testing

Safety and Efficacy of Secukinumab in Mild Psoriasis

Who this might be right for
Psoriasis
James G. Krueger, MD, PhD 23
Large-scale testing (Phase 3)Study completedNCT02074982
What this trial is testing

Efficacy of Secukinumab Compared to Ustekinumab in Patients With Plaque-type Psoriasis

Who this might be right for
Chronic Plaque Type Psoriasis
Novartis Pharmaceuticals 676
Testing effectiveness (Phase 2)Study completedNCT01426789
What this trial is testing

A Biomarker Study of Secukinumab in Rheumatoid Arthritis (RA) Patients

Who this might be right for
Rheumatoid Arthritis
Novartis Pharmaceuticals 100
Post-approval studies (Phase 4)Study completedNCT04571567
What this trial is testing

Evaluate the Efficacy and Safety of Secukinumab in Adult Patients With Skin Types IV-VI With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Saakshi Khattri 20
Post-approval studies (Phase 4)Study completedNCT04535999
What this trial is testing

Open Label Study of the Effects of Secukinumab on Nail Psoriasis and Non-Invasive Measures of Enthesitis (Phase IV)

Who this might be right for
Psoriasis
University of Pennsylvania 16
Large-scale testing (Phase 3)Study completedNCT03066609
What this trial is testing

Study of Efficacy and Safety of Secukinumab in Subjects With Moderate to Severe Chronic Plaque-type Psoriasis

Who this might be right for
Plaque Psoriasis
Novartis Pharmaceuticals 543
Large-scale testing (Phase 3)Study completedNCT02474082
What this trial is testing

Study of Secukinumab Compared to Fumaderm® in Adults With Moderate to Severe Psoriasis.

Who this might be right for
Psoriasis
Novartis Pharmaceuticals 202
Testing effectiveness (Phase 2)Study completedNCT02854163
What this trial is testing

Effect of Secukinumab in the Treatment of Psoriatic Arthritis

Who this might be right for
Psoriatic Arthritis
University of Liverpool 30
Not applicableLooking for participantsNCT07282015
What this trial is testing

Real-world Secukinumab Outcomes in Canadian HS Patients

Who this might be right for
Hidradenitis Suppurativa
Novartis Pharmaceuticals 142
Testing effectiveness (Phase 2)Study completedNCT02733094
What this trial is testing

Single-arm Study to Assess a Potential Effect of Anti-IL-17 (Secukinumab) in the Treatment of Pyoderma Gangrenosum

Who this might be right for
Pyoderma Gangrenosum
Technical University of Munich 8
Not applicableActive Not RecruitingNCT06785675
What this trial is testing

Assessing Short-term Treatment Satisfaction and Quality of Life in Patients With Hidradenitis Suppurativa Initiated on Secukinumab.

Who this might be right for
Hidradenitis Suppurativa
Novartis Pharmaceuticals 48
Large-scale testing (Phase 3)Study completedNCT03478787
What this trial is testing

Risankizumab Versus Secukinumab for Participants With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
AbbVie 327
Not applicableStudy completedNCT06172426
What this trial is testing

Incidence of Psoriatic Arthritis Among Psoriasis Patients Newly Initiated With Secukinumab in a US Claims Database and a UK Registry

Who this might be right for
Psoriatic ArthritisPsoriasis
Novartis Pharmaceuticals 1,171
Not applicableStudy completedNCT05344482
What this trial is testing

Evaluation of the Effectiveness of Secukinumab in Patients With Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Novartis Pharmaceuticals 277
Large-scale testing (Phase 3)Study completedNCT02745080
What this trial is testing

Efficacy of Secukinumab Compared to Adalimumab in Patients With Psoriatic Arthritis

Who this might be right for
Psoriatic Arthritis
Novartis Pharmaceuticals 853
Post-approval studies (Phase 4)Study completedNCT05676333
What this trial is testing

Secukinumab in Active Non-segmental Vitiligo

Who this might be right for
VitiligoSecukinumab
University Hospital, Ghent 8
Large-scale testing (Phase 3)Study completedNCT02159053
What this trial is testing

16-week Efficacy and 2-year Safety, Tolerability and Efficacy of Secukinumab in Participants With Active Ankylosing Spondylitis

Who this might be right for
Spondylitis, Ankylosing
Novartis Pharmaceuticals 350
Post-approval studies (Phase 4)Study completedNCT02592018
What this trial is testing

Immunologic Response to Secukinumab in Plaque Psoriasis

Who this might be right for
Psoriasis
University of California, San Francisco 15
Large-scale testing (Phase 3)Study completedNCT05380453
What this trial is testing

Efficacy and Safety of Secukinumab in Patients With New Onset of Giant Cell Arteritis Who Are in Clinical Remission

Who this might be right for
Giant Cell Arteritis
Novartis Pharmaceuticals 151
Not applicableUnknownNCT02835716
What this trial is testing

Pre-Clinical (Alzheimers) Diagnosis PCD = Optimum Outcomes OO

Who this might be right for
Alzheimer Disease
Millennium Magnetic Technologies, LLC 150
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation